Primary and Secondary Prevention of Sudden Cardiac Death in Ischemic Heart Disease and Myocardiopathies: Do Drugs Have any Role? - Juergen Kuschyck

↳ This is a section part of Moment: ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$19.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Primary and Secondary Prevention of Sudden Cardiac Death in Ischemic Heart Disease and Myocardiopathies: Do Drugs Have any Role? - Presented by Juergen Kuschyck at ISCP 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$19.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Cardiologists, interventional Cardiologists
Interventional Fellows
Interventional Radiologists
Vascular Surgeons
Emergency Physicians

Learning Objectives

Other Components in this Moment

Overview

Welcome and Opening Ceremony of the ISCP Congress 2017 - Antoni Martínez-Rubio

Syncope: Differential Diagnoses and Signs of High Risk - Ángel Moya

Pharmacotherapy in Neurocardiogenic Syncope: New Options - Carlos Morillo

Primary and Secondary Prevention of Sudden Cardiac Death in Ischemic Heart Disease and Myocardiopathies: Do Drugs Have any Role? - Juergen Kuschyck

Primary and Secondary Prevention of Sudden Cardiac Death in Channelopathies: Role of Drugs and Devices - Josep Brugada

The interplay Between Atrial Fibrillation and Sudden Cardiac Death - Martin Borggrefe

Current Perspectives on the Use of Digoxin - Mohammad Shenasa

Discussion of ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy